stockportfolio.pro
Stocks / AXSM vs RVTY
AXSM vs RVTY: Which Stock Is the Better Buy?
Axsome Therapeutics, Inc. and Revvity, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AXSM is the larger company ($13.0B vs $12.7B). On the fundamentals, RVTY earns a higher net margin (8.4% vs -28.7%); RVTY has the stronger return on equity (3.3% vs -207.5%). On the filings, RVTY carries fewer potential red flags (2 vs 3). Full numbers below — the stronger figure on each row is in green.
AI verdict — AXSM vs RVTY, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Axsome Therapeutics, Inc. (AXSM) | Revvity, Inc. (RVTY) | |
|---|---|---|
| Market cap | $13.0B | $12.7B |
| Revenue (latest FY) | $638.50M | $2.86B |
| Net income (latest FY) | $-183.17M | $241.20M |
| Revenue growth (5y CAGR) | — | -5.5% |
| Net margin | -28.7% | 8.4% |
| Return on equity | -207.5% | 3.3% |
| P/E ratio | — | 54.7 |
| Dividend yield | — | 0.3% |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | No | Yes |
Compare with another company:
See the full AXSM vs RVTY breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open AXSM's full financials → Open RVTY's full financials →More comparisons
Frequently asked questions
Which is bigger, AXSM or RVTY?
Axsome Therapeutics, Inc. is larger by market capitalization — $13.0B versus $12.7B.
Which grows faster, AXSM or RVTY?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.